Your Article Summary
See Latest ArticlesGene expression signatures, clinicopathological features, and individualized therapy in breast cancer
JAMA, 04/03/08
Acharya CR et al. - Incorporation of gene expression signatures into clinical risk stratification can refine prognosis
Methods- Retrospective study of early stage breast carcinoma candidates for adjuvant chemotherapy
- Review of microarray data for 964 clinically annotated breast tumor samples (573 in initial set; 391 in validation cohort)
- Relapse risk scores based on respective clinicopathologic features
- Main outcome measures: gene expression signatures and clinicopathological variables in early stage breast cancer to determine a refined estimation of relapse-free survival and sensitivity to chemotherapy
- In initial 573 pts, prognostically significant clusters as patterns of oncogenic pathway activation and tumor biology/microenvironment states were identified within the low-, intermediate-, and high-risk model cohorts
- Multivariate analyses confirmed independent prognostic value of genomic clusters
- Related, not identical, clusters in the independent validation cohort established reproducibility and validity of pathway deregulation patterns in predicting relapse risk
- The prognostic clinicogenomic clusters showed unique sensitivity patterns to commonly used cytotoxic therapies
Related Articles
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 74%
Advanced Breast Cancer and Breast Cancer Mortality in Randomized Controlled Trials on Mammography Screening
Journal of Clinical Oncology, 11/09/09
Relevance Score: 72%
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients
Breast Cancer Research and Treatment, 10/27/09
Relevance Score: 72%
Underweight and breast cancer recurrence and death: A report from the Korean breast cancer society
Journal of Clinical Oncology, 10/08/09
Relevance Score: 72%
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study
Cancer Epidemiology, Biomarkers & Prevention, 10/01/09
Relevance Score: 72%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Smoking Status and Pain Level Among Head and Neck Cancer Patients
The Journal of Pain, 12/17/09
Delay in Diagnostic Workup and Treatment of Esophageal Cancer
Journal of Gastrointestinal Surgery, 12/17/09
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/17/09
Omega-3 fatty acids and cognitive function in women
Women's Health, 12/17/09
Emotional Regulation and Acute Pain Perception in Women
The Journal of Pain, 12/17/09